BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 26332050)

  • 21. Incidence and pathological features of prostate cancer detected on transperineal template guided mapping biopsy after negative transrectal ultrasound guided biopsy.
    Bittner N; Merrick GS; Butler WM; Bennett A; Galbreath RW
    J Urol; 2013 Aug; 190(2):509-14. PubMed ID: 23416641
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic value of MRI-based PSA density in predicting transperineal sector-guided prostate biopsy outcomes.
    MacAskill F; Lee SM; Eldred-Evans D; Wulaningsih W; Popert R; Wolfe K; Van Hemelrijck M; Rottenberg G; Liyanage SH; Acher P
    Int Urol Nephrol; 2017 Aug; 49(8):1335-1342. PubMed ID: 28477301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging and Fusion Guided Targeted Biopsy Evaluated by Transperineal Template Saturation Prostate Biopsy for the Detection and Characterization of Prostate Cancer.
    Mortezavi A; Märzendorfer O; Donati OF; Rizzi G; Rupp NJ; Wettstein MS; Gross O; Sulser T; Hermanns T; Eberli D
    J Urol; 2018 Aug; 200(2):309-318. PubMed ID: 29474846
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multicentre evaluation of magnetic resonance imaging supported transperineal prostate biopsy in biopsy-naïve men with suspicion of prostate cancer.
    Hansen NL; Barrett T; Kesch C; Pepdjonovic L; Bonekamp D; O'Sullivan R; Distler F; Warren A; Samel C; Hadaschik B; Grummet J; Kastner C
    BJU Int; 2018 Jul; 122(1):40-49. PubMed ID: 29024425
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy.
    Nakai Y; Tanaka N; Anai S; Miyake M; Hori S; Tatsumi Y; Morizawa Y; Fujii T; Konishi N; Fujimoto K
    BMC Urol; 2017 Apr; 17(1):28. PubMed ID: 28381267
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transperineal template-guided saturation biopsy using a modified technique: outcome of 270 cases requiring repeat prostate biopsy.
    Ekwueme K; Simpson H; Zakhour H; Parr NJ
    BJU Int; 2013 Jun; 111(8):E365-73. PubMed ID: 23714648
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Efficacy of Transrectal Ultrasound Guided Biopsy Versus Transperineal Template Biopsy of the Prostate in Diagnosing Prostate Cancer in Men with Previous Negative Transrectal Ultrasound Guided Biopsy.
    Nafie S; Wanis M; Khan M
    Urol J; 2017 Mar; 14(2):3008-3012. PubMed ID: 28299763
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transperineal prostate biopsy detects significant cancer in patients with elevated prostate-specific antigen (PSA) levels and previous negative transrectal biopsies.
    Dimmen M; Vlatkovic L; Hole KH; Nesland JM; Brennhovd B; Axcrona K
    BJU Int; 2012 Jul; 110(2 Pt 2):E69-75. PubMed ID: 22093091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of prostate-specific antigen density on positive and negative predictive values of multiparametric magnetic resonance imaging to detect Gleason score 7-10 prostate cancer in a repeat biopsy setting.
    Hansen NL; Barrett T; Koo B; Doble A; Gnanapragasam V; Warren A; Kastner C; Bratt O
    BJU Int; 2017 May; 119(5):724-730. PubMed ID: 27488931
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of transperineal template prostate biopsies in restaging men with prostate cancer managed by active surveillance.
    Ayres BE; Montgomery BS; Barber NJ; Pereira N; Langley SE; Denham P; Bott SR
    BJU Int; 2012 Apr; 109(8):1170-6. PubMed ID: 21854535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors influencing urinary retention after transperineal template biopsy of the prostate: outcomes from a regional cancer centre.
    Kum F; Jones A; Nigam R
    World J Urol; 2019 Feb; 37(2):337-342. PubMed ID: 29974188
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound-guided biopsy: the Victorian Transperineal Biopsy Collaboration experience.
    Ong WL; Weerakoon M; Huang S; Paul E; Lawrentschuk N; Frydenberg M; Moon D; Murphy D; Grummet J
    BJU Int; 2015 Oct; 116(4):568-76. PubMed ID: 25560926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The ability of prostate-specific antigen (PSA) density to predict an upgrade in Gleason score between initial prostate biopsy and prostatectomy diminishes with increasing tumour grade due to reduced PSA secretion per unit tumour volume.
    Corcoran NM; Casey RG; Hong MK; Pedersen J; Connolly S; Peters J; Harewood L; Gleave ME; Costello AJ; Hovens CM; Goldenberg SL
    BJU Int; 2012 Jul; 110(1):36-42. PubMed ID: 22085203
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols.
    Philip J; Hanchanale V; Foster CS; Javlé P
    BJU Int; 2006 Sep; 98(3):559-62. PubMed ID: 16925754
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Accuracy of primary systematic template guided transperineal biopsy of the prostate for locating prostate cancer: a comparison with radical prostatectomy specimens.
    Huo AS; Hossack T; Symons JL; PeBenito R; Delprado WJ; Brenner P; Stricker PD
    J Urol; 2012 Jun; 187(6):2044-9. PubMed ID: 22498226
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Magnetic Resonance and Ultrasound Image Fusion Supported Transperineal Prostate Biopsy Using the Ginsburg Protocol: Technique, Learning Points, and Biopsy Results.
    Hansen N; Patruno G; Wadhwa K; Gaziev G; Miano R; Barrett T; Gnanapragasam V; Doble A; Warren A; Bratt O; Kastner C
    Eur Urol; 2016 Aug; 70(2):332-40. PubMed ID: 26995327
    [TBL] [Abstract][Full Text] [Related]  

  • 37. What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.
    Moldovan PC; Van den Broeck T; Sylvester R; Marconi L; Bellmunt J; van den Bergh RCN; Bolla M; Briers E; Cumberbatch MG; Fossati N; Gross T; Henry AM; Joniau S; van der Kwast TH; Matveev VB; van der Poel HG; De Santis M; Schoots IG; Wiegel T; Yuan CY; Cornford P; Mottet N; Lam TB; Rouvière O
    Eur Urol; 2017 Aug; 72(2):250-266. PubMed ID: 28336078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Magnetic resonance imaging-directed transperineal limited-mapping prostatic biopsies to diagnose prostate cancer: a Scottish experience.
    Mukherjee A; Morton S; Fraser S; Salmond J; Baxter G; Leung HY
    Scott Med J; 2014 Nov; 59(4):204-8. PubMed ID: 25314954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination of prostate imaging reporting and data system (PI-RADS) score and prostate-specific antigen (PSA) density predicts biopsy outcome in prostate biopsy naïve patients.
    Washino S; Okochi T; Saito K; Konishi T; Hirai M; Kobayashi Y; Miyagawa T
    BJU Int; 2017 Feb; 119(2):225-233. PubMed ID: 26935594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic transperineal ultrasound-guided template biopsy of the prostate: three-year experience.
    Pinkstaff DM; Igel TC; Petrou SP; Broderick GA; Wehle MJ; Young PR
    Urology; 2005 Apr; 65(4):735-9. PubMed ID: 15833518
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.